Autopsy report · NCT00582205

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

“Study completed per investigator.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 11 months after it had already started.
• Ran for about 5 years 11 months before it stopped.
• 21 participants enrolled.
• Results were posted on the registry 5 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Oklahoma

Sponsor type

University, hospital or other

Conditions

Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Uterine Cancer

Interventions

Paclitaxel, Cisplatin IP

Participants

21

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.